Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/REPARE-THERAPEUTICS-INC-108596811/nieuws/Repare-Therapeutics-doneert-eerste-patient-in-Fase-1-klinische-studie-met-RP-1664-45962938/?utm_source=whatsapp&utm_medium=social&utm_campaign=share